These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 747146)
21. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
22. [Management in pollinosis and false pollinosis]. Tabart J; Gallois JR; Marland P; Fleury P Ann Otolaryngol Chir Cervicofac; 1978 Dec; 95(12):733-46. PubMed ID: 36022 [TBL] [Abstract][Full Text] [Related]
23. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883 [TBL] [Abstract][Full Text] [Related]
24. [Hyposensitization in pollinosis. Results of a 3-year controlled study with 2 depot-allergoid grass pollen extracts: aluminum hydroxide-adsorbed allergoid and tyrosine-adsorbed allergoid]. Mühlethaler K; Wüthrich B; Peeters AG; Terki N; Girard JP; Frank E Schweiz Rundsch Med Prax; 1990 Apr; 79(14):430-6. PubMed ID: 2188335 [TBL] [Abstract][Full Text] [Related]
25. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270 [TBL] [Abstract][Full Text] [Related]
26. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G; Hurley C; Turcanu V; Lack G J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [TBL] [Abstract][Full Text] [Related]
27. [Hyposensitization with cross-reacting pollen allergens]. Karl S; Rakoski J Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627 [TBL] [Abstract][Full Text] [Related]
28. Hyposensitization in allergic rhinitis--a comparison of aqueous extracts and Allpyral by means of rhinomanometry. Aschan G; Irander K; Olofsson J J Otolaryngol; 1978 Oct; 7(5):444-9. PubMed ID: 739576 [TBL] [Abstract][Full Text] [Related]
29. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
30. [Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen]. MMW Fortschr Med; 2004 Mar; 146(11):58. PubMed ID: 15152778 [No Abstract] [Full Text] [Related]
31. [Specific hyposensitization using pyridine extracts precipitated with aluminum. III. Intolerance to the extracts. Anatomo-pathological study of the receptor area]. Basomba A; Tamarit L; Peláez A; Villalmanzo IG Allergol Immunopathol (Madr); 1974; 2(5):325-32. PubMed ID: 4218447 [No Abstract] [Full Text] [Related]
32. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565 [TBL] [Abstract][Full Text] [Related]
33. [Late results of hyposensitization therapy of pollinosis. Follow-up studies of 328 cases 2-5 years after termination of injection treatment with aqueous or semi-depot allergen extracts]. Wüthrich B; Günthard HP Schweiz Med Wochenschr; 1974 May; 104(20):713-7. PubMed ID: 4829628 [No Abstract] [Full Text] [Related]
34. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. Smith H; White P; Annila I; Poole J; Andre C; Frew A J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323 [TBL] [Abstract][Full Text] [Related]
35. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Hordijk GJ; Antvelink JB; Luwema RA Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731 [TBL] [Abstract][Full Text] [Related]
36. A comparison of two grass pollen extracts in the treatment of hay fever. Horak F; Watson K Allergol Immunopathol (Madr); 1987; 15(2):59-64. PubMed ID: 3618442 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ; Powell RJ; Corrigan CJ; Durham SR; J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. Colás C; Monzón S; Venturini M; Lezaun A J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938 [TBL] [Abstract][Full Text] [Related]
39. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808 [TBL] [Abstract][Full Text] [Related]
40. [Hyposensitization treatment of allergic diseases]. Wüthrich B Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]